Physician profile
Lewis E Porter
NPI 1407883044
$3,042.18
in general payments reported to CMS, 2019-2025
29 companies · $1,515 in 2025
The $1,515 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $327 · 2021: $308 · 2022: $160 · 2023: $153 · 2024: $227 · 2025: $1,515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086 · Travel and Lodging: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,085.86 |
| Travel and Lodging | $809.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,068.69 | 2025 | |
| Kerecis Limited | $241.20 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $209.61 | 2019-2025 | Collagenase Santyl, Stravix |
| Tela Bio, INC. | $200.36 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Musculoskeletal Transplant Foundation INC. | $200.00 | 2020 | |
| Phathom Pharmaceuticals, INC. | $170.84 | 2024-2025 | Voquezna |
| Redhill Biopharma INC. | $143.32 | 2021-2024 | Talicia |
| W. L. Gore & Associates, INC. | $109.37 | 2019-2024 | Gore Synecor Biomaterial |
| Intuitive Surgical, INC. | $102.55 | 2019 | |
| Kci USA, INC. | $57.51 | 2019-2023 | V.A.C. Dermatac, Activ.A.C. |
| Innovation Technologies INC | $55.71 | 2024-2025 | Irrisept |
| Teleflex LLC | $49.33 | 2022-2025 | Deknatel, Titan Sgs Bailout Chuck |
| Integra Lifesciences Corporation | $47.83 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $40.30 | 2022-2023 | Seglentis |
| Baxter Healthcare | $37.91 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $31.80 | 2019-2023 | Saxenda, Wegovy |
| Acera Surgical, INC. | $31.52 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $30.29 | 2022-2024 | Onzetra Xsail, Contrave |
| Acell, INC. | $28.14 | 2020 | |
| Polynovo North America LLC | $23.74 | 2025 | Novosorb Btm |
| Davol INC. | $23.15 | 2019 | |
| Merck Sharp & Dohme LLC | $21.70 | 2025 | Keytruda, Lynparza |
| Ethicon US, LLC | $20.79 | 2023 | Echelon Circular, Echelon; Endopath |
| Elutia, INC. | $19.26 | 2020 | |
| Solventum Corporation | $18.12 | 2025 | V.A.C. Veraflo, Activ.A.C. |
| Nestle Healthcare Nutrition INC. | $17.07 | 2023 | |
| Innocoll Pharmaceuticals Limited | $15.83 | 2021 | |
| Medtronic Vascular, INC. | $14.76 | 2019 | |
| Braintree Laboratories, INC. | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lewis Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.